View Exam | PowerPak

1. Which of the following statements regarding diagnostic testing for influenza is true?

A. Rapid influenza diagnostic tests (RIDTs) have been shown to have high sensitivity. B. Nucleic acid amplification tests (NAATs) typically have a turnaround time of 15 to 30 minutes. C. When influenza prevalence is relatively high, false-positive results are more likely. D. The Centers for Disease Control and Prevention recommends that clinicians wait for the results of influenza and coronavirus disease (COVID-19) testing before initiating antiviral therapy.

2. Which of the following statements regarding treatment of a 28-year-old man with a body mass index (BMI) of 41 kg/m² who is suspected of having influenza is true?

A. He is at low risk for complications. B. Treatment should be withheld pending definitive confirmation of influenza infection. C. He should not be treated with antiviral agents if symptom onset was ≥72 hours ago. D. A BMI of 41 kg/m² puts him in a high-risk group.

3. Which of the following statements regarding baloxavir marboxil in the CAPSTONE-2 trial is true?

A. Baloxavir was associated with a higher rate of antibiotic use than oseltamivir. B. Baloxavir, but not oseltamivir, reduced the time to clinical recovery versus placebo. C. Baloxavir was superior to oseltamivir in reducing the time to clinical recovery among the subgroup of participants with influenza B infection. D. Baloxavir was superior to oseltamivir in reducing the time to clinical recovery among the subgroup of participants with influenza A infection.

4. You are seeing an 8-year-old patient who has had cough, fever, and myalgias for 36 hours. Influenza NAAT is positive for influenza B, and you prescribe an antiviral. She lives at home with her 50-year-old mother who has asthma and emphysema, is receiving chemotherapy for lung cancer, and was vaccinated for influenza 1 week ago. What is the most prudent influenza prophylaxis medication for her mother?

A. None, because she has been vaccinated B. Baloxavir C. Oseltamivir D. Zanamivir

5. A 16-year-old girl presents to your office after 12 hours of fevers, chills, and muscle aches. She has a history of moderate asthma and has been hospitalized for this condition 4 times in the past. Office-based polymerase chain reaction testing shows that she has influenza type B. According to clinical data, which of the following treatments is the most likely to reduce the time to symptom improvement?

A. Baloxavir B. Zanamivir C. Oseltamivir D. Amantadine

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following statements regarding diagnostic testing for influenza is true?

2. Which of the following statements regarding treatment of a 28-year-old man with a body mass index (BMI) of 41 kg/m² who is suspected of having influenza is true?

3. Which of the following statements regarding baloxavir marboxil in the CAPSTONE-2 trial is true?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following statements regarding diagnostic testing for influenza is true?

2. Which of the following statements regarding treatment of a 28-year-old man with a body mass index (BMI) of 41 kg/m2 who is suspected of having influenza is true?

3. Which of the following statements regarding baloxavir marboxil in the CAPSTONE-2 trial is true?

« Return to Activity

Customers who Purchased
this Activity also Purchased

2. Which of the following statements regarding treatment of a 28-year-old man with a body mass index (BMI) of 41 kg/m² who is suspected of having influenza is true?